Prevalence and pathogenicity of Clostridium difficile in hospitalized patients - A french multicenter study

被引:118
作者
Barbut, F
Corthier, G
Charpak, Y
Cerf, M
Monteil, H
Fosse, T
Trevoux, A
DeBarbeyrac, B
Boussougant, Y
Tigaud, S
Tytgat, F
Sedallian, A
Duborgel, S
Collignon, A
LeGuern, ME
Bernasconi, P
Petit, JC
机构
[1] INRA,LAB ECOL & PHYSIOL GASTROINTESTINAL TRACT,JOUY EN JOSAS,FRANCE
[2] SOC EVAL,PARIS,FRANCE
[3] HOP LOUIS MOURIER,SERV HEPATOGASTROENTEROL,F-92701 COLOMBES,FRANCE
[4] HOP LOUIS MOURIER,BACTERIOL SERV,F-92701 COLOMBES,FRANCE
[5] UNIV LOUIS PASTEUR STRASBOURG 1,INST BACTERIOL,STRASBOURG,FRANCE
[6] HOP LOUIS PASTEUR,BACTERIOL LAB,F-06002 NICE,FRANCE
[7] HOP EMILE MULLER,BACTERIOL SERV,MULHOUSE,FRANCE
[8] GRP HOSP PELLEGRIN TRIPODE,BACTERIOL SERV,BORDEAUX,FRANCE
[9] HOP CROIX ROUSSE,MICROBIOL SERV,F-69317 LYON,FRANCE
[10] CTR HOSP ST CATHERINE,BACTERIOL SERV,SAVERNE,FRANCE
[11] CTR HOSP,BACTERIOL SERV,ANNECY,FRANCE
[12] FAC MED,BACTERIOL SERV,GRENOBLE,FRANCE
[13] HOP JEAN VERDIER,BACTERIOL SERV,BONDY,FRANCE
[14] LAB BIOCODEX,PARIS,FRANCE
关键词
D O I
10.1001/archinte.156.13.1449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although Clostridium difficile is the main agent responsible for nosocomial diarrhea in adults, its prevalence in stool cultures sent to hospital microbiology laboratories is not clearly established. Objectives: To determine the prevalence of C difficile in inpatient stools sent to hospital microbiology laboratories and to assess the relationship between serotypes and toxigenicity of the strains isolated and the clinical data. Methods: From January 18, 1993, to July 31, 1993, the presence of C difficile was systematically investigated in a case-control study on 3921 stool samples sent for stool culture to 11 French hospital microbiology laboratories. The prevalence of C difficile in this population (cases) was compared with that of a group of 229 random hospital controls matched for age, department, and length of stay (controls). Stool culture from controls was requested by the laboratory although not prescribed by the clinical staff. Serotype and toxigenesis of the strains isolated were compared. Results: The overall prevalence of C difficile in the cases was twice the prevalence in the controls (9.7% vs 4.8%; P<.001) and was approximately 4 times as high in diarrheal stools tie, soft or liquid) as in normally formed stools from controls (11.5% vs 3.3%; P<.001). The strains isolated from diarrheal stools were more frequently toxigenic than those isolated from normally formed stools. Serogroup D was never toxigenic, and its proportion was statistically greater in the controls than in the cases (45% vs 18%; chi(2)=5.2; P<.05). Conversely, serogroup C was isolated only from the cases. Clostridium difficile was mainly found in older patients (>65 years), suffering from a severe disabling disease, who had been treated with antibiotics and hospitalized for more than 1 week in long-stay wards or in intensive care. Conclusions: This multicenter period prevalence study clearly supports the hypothesis of a common role of C difficile in infectious diarrhea in hospitalized patients. Disease associated with C difficile should therefore be systematically evaluated in diarrheal stools from inpatients.
引用
收藏
页码:1449 / 1454
页数:6
相关论文
共 27 条
[1]   ANTIMICROBIAL AGENTS AND CLOSTRIDIUM-DIFFICILE IN ACUTE ENTERIC DISEASE - EPIDEMIOLOGICAL DATA FROM SWEDEN, 1980-1982 [J].
ARONSSON, B ;
MOLLBY, R ;
NORD, CE .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :476-481
[2]   COMPARISON OF 3 ENZYME IMMUNOASSAYS, A CYTOTOXICITY ASSAY, AND TOXIGENIC CULTURE FOR DIAGNOSIS OF CLOSTRIDIUM-DIFFICILE ASSOCIATED DIARRHEA [J].
BARBUT, F ;
KAJZER, C ;
PLANAS, N ;
PETIT, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (04) :963-967
[3]  
BRTTLE RP, 1982, LANCET, V1, P1193
[4]   ACQUISITION OF CLOSTRIDIUM-DIFFICILE BY HOSPITALIZED-PATIENTS - EVIDENCE FOR COLONIZED NEW ADMISSIONS AS A SOURCE OF INFECTION [J].
CLABOTS, CR ;
JOHNSON, S ;
OLSON, MM ;
PETERSON, LR ;
GERDING, DN .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :561-567
[5]   PROTECTION AGAINST EXPERIMENTAL PSEUDOMEMBRANOUS COLITIS IN GNOTOBIOTIC MICE BY USE OF MONOCLONAL-ANTIBODIES AGAINST CLOSTRIDIUM-DIFFICILE TOXIN-A [J].
CORTHIER, G ;
MULLER, MC ;
WILKINS, TD ;
LYERLY, D ;
LHARIDON, R .
INFECTION AND IMMUNITY, 1991, 59 (03) :1192-1195
[6]   MULTICENTER EVALUATION OF A NEW ENZYME-IMMUNOASSAY FOR DETECTION OF CLOSTRIDIUM-DIFFICILE ENTEROTOXIN-A [J].
DEGIROLAMI, PC ;
HANFF, PA ;
EICHELBERGER, K ;
LONGHI, L ;
TERESA, H ;
PRATT, J ;
CHENG, A ;
LETOURNEAU, JM ;
THORNE, GM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1085-1088
[7]   EPIDEMIOLOGY AND PREVENTION OF CLOSTRIDIUM-DIFFICILE INFECTIONS IN A LEUKEMIA UNIT [J].
DELMEE, M ;
VANDERCAM, B ;
AVESANI, V ;
MICHAUX, JL .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (06) :623-627
[8]   SEROGROUPING OF CLOSTRIDIUM-DIFFICILE STRAINS BY SLIDE AGGLUTINATION [J].
DELMEE, M ;
HOMEL, M ;
WAUTERS, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) :323-327
[9]  
DELMEE M, 1993, J CLIN MICROBIOL, V31, P2526
[10]   VIRULENCE OF 10 SEROGROUPS OF CLOSTRIDIUM-DIFFICILE IN HAMSTERS [J].
DELMEE, M ;
AVESANI, V .
JOURNAL OF MEDICAL MICROBIOLOGY, 1990, 33 (02) :85-90